Pigmentary disorders


Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites


    Related Conference of Pigmentary disorders

    March 01-02, 2023

    7th International Congress on Dermatology

    Berlin, Germany
    April 05-06, 2023

    Global Summit on Skin care and Cosmetology

    Madrid, Spain
    May 22-23, 2023

    24th World Dermatology Congress

    Barcelona, Spain
    July 17-18, 2023

    12th International Conference on Cosmetology & Beauty

    Zurich, Switzerland
    July 27-28, 2023

    23rd European Dermatology Congress

    Paris, France
    September 18-19, 2023

    6th World Cosmetic and Dermatology Congress

    Barcelona, Spain
    September 25-26, 2023

    9th World Dermatology, Trichology and Aesthetic Congress

    Prague, Czech Republic
    September 25-26, 2023

    19th International Conference on Dermatopathology

    Taipei, Taiwan
    November 09-10, 2023

    25th World Dermatology and Aesthetic Congress

    Stockholm, Sweden
    November 20-21, 2023

    3rd Global Summit on Skincare and Plastic Aesthetic

    Bangkok, Thailand
    December 14-15, 2023

    7th Annual Conference on Skin Cancer and Dermatology

    Rome, Italy

    Pigmentary disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in